NEURO2024

Presentation information

Symposia

[2S09m] New breakthroughs in understanding cancer pathology and cancer pain: Innovation in cancer research by "Cancer Neuroscience".

Thu. Jul 25, 2024 8:45 AM - 10:45 AM Room 9 (402+403)

Organizer: Yasuyuki Nagumo (Division of Cancer Pathophysiology, National Cancer Center Research Institute)

[2S09m-03] Conditional expression and activation of designer receptors exclusively activated by designer drugs (DREADD) reveals novel impact of neuron-tumor communications on brain tumor progression

*Daisuke Kawauchi1, Naofumi Uesaka2 (1. Grad Sch Med Sci, Nagoya City Univ, Nagoya, Japan, 2. Grad Sch Med and Dent Sci, Tokyo Medical and Dental Univ, Tokyo, Japan.)

Keywords:Brain tumor, Chemogenetics, Trans-synaptic retrograde labeling, Ca2+ signal

Please log in with your participant account.
» Participant Log In